Products for Research Use Only
RegisterLogin

IMM-H007

CAT: 0804-HY-141645-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-141645-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IMM-H007 (WS070117) is an orally active and potent AMPK (AMP-activated protein kinase) activator and TGFβ1 (transforming growth factor β1) antagonist. IMM-H007 has protective effects in cardiovascular diseases via activation of AMPK. IMM-H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. IMM-H007 inhibits ABCA1 degradation. IMM-H007 resolves hepatic steatosis in HFD-fed hamsters by the regulation of lipid metabolism. IMM-H007 can be used for the research of nonalcoholic fatty liver disease (NAFLD) and inflammatory atherosclerosis[1][2][3].
CAS Number
1221412-23-2
Product Name Alternative
WS070117
UNSPSC
12352005
Target
AMPK; AP-1; JNK; NF-κB; TGF-β Receptor
Type
Reference compound
Related Pathways
Epigenetics; Immunology/Inflammation; MAPK/ERK Pathway; NF-κB; PI3K/Akt/mTOR; TGF-beta/Smad
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/imm-h007.html
Purity
97.69
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CC(O[C@H]1[C@@](N2C3=NC=NC(NC4=CC(O)=CC=C4)=C3N=C2)([H])O[C@@H]([C@H]1OC(C)=O)COC(C)=O)=O
Molecular Formula
C22H23N5O8
Molecular Weight
485.45
References & Citations
[1]Yu J, et al. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling. Toxicol Appl Pharmacol. 2019 Oct 15;381:114732.|[2]Shi H, et al. IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet. FEBS Open Bio. 2017 Aug 29;7 (9) :1379-1391.|[3]Wang SX, et al. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway. Acta Pharmacol Sin. 2022 Mar 30.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-123357IMM-H004
HY-121490IMM-02
HY-124808-01IMM-01
HY-P991186IMM-20059
HY-180348KFP-H008
HY-P990606IMMU-114
HY-167840-01IMMH-010 (maleate)
HY-101496-01MT-DADMe-ImmA
HY-P705542Immt, Rat (Cell-Free, His)
HY-RS06792IMMT Human Pre-designed siRNA Set A

Alternative Products

CatalogName
BA4637-25IMM-H007
MBS3616399-01IMM-01
GTR17982709Imm Antibody
GTR19223483-01IMM-03

Popular Products